Bertrand Cariou CHU Nantes, CNRS, INSERM, l'institut du thorax Nantes Université Biography Publications Institution JoVE Articles Bertrand Cariou has not added a biography. If you are Bertrand Cariou and would like to personalize this page please email our Author Liaison for assistance. Publications Early Humoral Response to COVID-19 Vaccination in Patients Living with Obesity and Diabetes in France. The COVPOP OBEDIAB Study with Results from the ANRS0001S COV-POPART Cohort Metabolism: Clinical and Experimental. Jan, 2023 | Pubmed ID: 36731720 Lipid-lowering Efficacy and Safety of Alirocumab in a Real-life Setting in France: Insights from the ODYSSEY APPRISE Study Archives of Cardiovascular Diseases. Jan, 2023 | Pubmed ID: 36535853 Plasma Level of ATPase Inhibitory Factor 1 (IF1) is Associated with Type 2 Diabetes Risk in Humans: A Prospective Cohort Study Diabetes & Metabolism. Jan, 2023 | Pubmed ID: 36174852 Effects of Parathyroidectomy on Kidney Function in Patients with Primary Hyperparathyroidism: Results of a Prospective Study Surgery. Jan, 2023 | Pubmed ID: 36167701 Associations of Microvascular Complications with All-cause Death in Patients with Diabetes and COVID-19: The CORONADO, ABCD COVID-19 UK National Audit and AMERICADO Study Groups Diabetes, Obesity & Metabolism. Jan, 2023 | Pubmed ID: 36053971 A New 165-SNP Low-density Lipoprotein Cholesterol Polygenic Risk Score Based on Next Generation Sequencing Outperforms Previously Published Scores in Routine Diagnostics of Familial Hypercholesterolemia Translational Research : the Journal of Laboratory and Clinical Medicine. Dec, 2022 | Pubmed ID: 36528340 Renal Function Decline and Heart Failure Hospitalisation in Patients with Type 2 Diabetes: Dynamic Predictions from the Prospective SURDIAGENE Cohort Diabetes Research and Clinical Practice. Dec, 2022 | Pubmed ID: 36375567 FACS-assisted CRISPR-Cas9 Genome Editing of Human Induced Pluripotent Stem Cells STAR Protocols. Dec, 2022 | Pubmed ID: 36115027 Variants in the Gene Are Associated With a Favorable Cardiometabolic Risk Profile Arteriosclerosis, Thrombosis, and Vascular Biology. Oct, 2022 | Pubmed ID: 36047410 Effect of the LDL Receptor Mutation Type on Incident Major Adverse Cardiovascular Events in Familial Hypercholesterolaemia European Journal of Preventive Cardiology. Nov, 2022 | Pubmed ID: 36047048 PCSK9 Deficiency Results in a Specific Shedding of Excess LDLR in Female Mice Only: Role of Hepatic Cholesterol Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids. Dec, 2022 | Pubmed ID: 35985474 Identification of a Gain-of-Function Variant As a Novel Cause of Familial Combined Hypocholesterolemia Circulation. Sep, 2022 | Pubmed ID: 35899625 Impact of Diabetes on COVID-19 Prognosis Beyond Comorbidity Burden: the CORONADO Initiative Diabetologia. Sep, 2022 | Pubmed ID: 35701673 Nutritional Biomarkers and Heart Failure Requiring Hospitalization in Patients with Type 2 Diabetes: the SURDIAGENE Cohort Cardiovascular Diabetology. Jun, 2022 | Pubmed ID: 35681209 CRISPR-Cas9 Engineering in Hypobetalipoproteinemia: A Promising Tool for Functional Studies of Novel Variants International Journal of Molecular Sciences. Apr, 2022 | Pubmed ID: 35457099 Generation of a GPR146 Knockout Human Induced Pluripotent Stem Cell Line (ITXi001-A-1) Stem Cell Research. Apr, 2022 | Pubmed ID: 35247835 COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO Study Current Diabetes Reports. Feb, 2022 | Pubmed ID: 35171448 Transintestinal Cholesterol Excretion in Health and Disease Current Atherosclerosis Reports. Mar, 2022 | Pubmed ID: 35138569 Plasma Apolipoprotein Concentrations and Incident Diabetes in Subjects with Prediabetes Cardiovascular Diabetology. Feb, 2022 | Pubmed ID: 35130909 PCSK9 Regulates the NODAL Signaling Pathway and Cellular Proliferation in HiPSCs Stem Cell Reports. Dec, 2021 | Pubmed ID: 34739847 Impact of Parathyroidectomy on Cardiovascular Risk in Primary Hyperparathyroidism: A Narrative Review Nutrition, Metabolism, and Cardiovascular Diseases : NMCD. Apr, 2021 | Pubmed ID: 33612382 Predictors of Hospital Discharge and Mortality in Patients with Diabetes and COVID-19: Updated Results from the Nationwide CORONADO Study Diabetologia. Apr, 2021 | Pubmed ID: 33599800 Phenotypic Characteristics and Prognosis of Newly Diagnosed Diabetes in Hospitalized Patients with COVID-19: Results from the CORONADO Study Diabetes Research and Clinical Practice. May, 2021 | Pubmed ID: 33577905 Routine Use of Statins and Increased COVID-19 Related Mortality in Inpatients with Type 2 Diabetes: Results from the CORONADO Study Diabetes & Metabolism. Mar, 2021 | Pubmed ID: 33091555 Euglycaemic Ketoacidosis During Gestational Diabetes with Concomitant COVID-19 Infection Diabetes & Metabolism. Mar, 2021 | Pubmed ID: 32738403 Comment on Chen Et Al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399-1407 Diabetes Care. Oct, 2020 | Pubmed ID: 32958626 Correction To: Phenotypic Characteristics and Prognosis of Inpatients with COVID-19 and Diabetes: the CORONADO Study Diabetologia. Sep, 2020 | Pubmed ID: 32617649 Phenotypic Characteristics and Prognosis of Inpatients with COVID-19 and Diabetes: the CORONADO Study Diabetologia. Aug, 2020 | Pubmed ID: 32472191 Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes The Journal of Clinical Endocrinology and Metabolism. Jul, 2020 | Pubmed ID: 32301490 Association Between Sleep Disturbances, Fear of Hypoglycemia and Psychological Well-being in Adults with Type 1 Diabetes Mellitus, Data from Cross-sectional VARDIA Study Diabetes Research and Clinical Practice. Feb, 2020 | Pubmed ID: 31866527 Circulating PCSK9 Levels Are Not Associated with the Conversion to Type 2 Diabetes Atherosclerosis. Jan, 2020 | Pubmed ID: 31835041 Bile Acids Associate with Glucose Metabolism, but Do Not Predict Conversion from Impaired Fasting Glucose to Diabetes Metabolism: Clinical and Experimental. Feb, 2020 | Pubmed ID: 31785259 EGF-A Peptides: A Promising Strategy for PCSK9 Inhibition Atherosclerosis. Jan, 2020 | Pubmed ID: 31784031 Severely Uncontrolled Diabetes: a New Aetiology of Acquired Bisalbuminaemia Diabetes & Metabolism. Sep, 2020 | Pubmed ID: 30660760 Comparative Efficacy, Safety, and Cardiovascular Outcomes with Once-weekly Subcutaneous Semaglutide in the Treatment of Type 2 Diabetes: Insights from the SUSTAIN 1-7 Trials Diabetes & Metabolism. Oct, 2019 | Pubmed ID: 30615985 PCSK9 Genetic Variants and Risk of Type 2 Diabetes: a Mendelian Randomisation Study The Lancet. Diabetes & Endocrinology. Feb, 2017 | Pubmed ID: 27908689 Glycaemic Control Influences the Relationship Between Plasma PCSK9 and LDL Cholesterol in Type 1 Diabetes Diabetes, Obesity & Metabolism. Mar, 2017 | Pubmed ID: 27804190 PCSK9 and Atherosclerosis: Beyond LDL-cholesterol Lowering Atherosclerosis. Oct, 2016 | Pubmed ID: 27591126 Efficacy of Alirocumab in High Cardiovascular Risk Populations with or Without Heterozygous Familial Hypercholesterolemia: Pooled Analysis of Eight ODYSSEY Phase 3 Clinical Program Trials International Journal of Cardiology. Nov, 2016 | Pubmed ID: 27573600 FGF21 Improves the Adipocyte Dysfunction Related to Seipin Deficiency Diabetes. Nov, 2016 | Pubmed ID: 27554469 Lipid Changes During Basal Insulin Peglispro, Insulin Glargine, or NPH Treatment in Six IMAGINE Trials Diabetes, Obesity & Metabolism. Nov, 2016 | Pubmed ID: 27486125 No Effect of PCSK9 Inhibitor Alirocumab on the Incidence of Diabetes in a Pooled Analysis from 10 ODYSSEY Phase 3 Studies European Heart Journal. Oct, 2016 | Pubmed ID: 27460890 Once-Daily Liraglutide Versus Lixisenatide As Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial Diabetes Care. Sep, 2016 | Pubmed ID: 27311491 Efficacy of Lixisenatide in Patients with Type 2 Diabetes: A Post Hoc Analysis of Patients with Diverse β-cell Function in the GetGoal-M and GetGoal-S Trials Journal of Diabetes and Its Complications. Sep-Oct, 2016 | Pubmed ID: 27267268 Identification of Novel APOB Mutations by Targeted Next-generation Sequencing for the Molecular Diagnosis of Familial Hypobetalipoproteinemia Atherosclerosis. Jul, 2016 | Pubmed ID: 27179706 Urine-sample-derived Human Induced Pluripotent Stem Cells As a Model to Study PCSK9-mediated Autosomal Dominant Hypercholesterolemia Disease Models & Mechanisms. Jan, 2016 | Pubmed ID: 26586530 Death, End-stage Renal Disease and Renal Function Decline in Patients with Diabetic Nephropathy in French Cohorts of Type 1 and Type 2 Diabetes Diabetologia. Jan, 2016 | Pubmed ID: 26486355 Vitamin D Deficiency is an Independent Risk Factor for PTDM After Kidney Transplantation Transplant International : Official Journal of the European Society for Organ Transplantation. Feb, 2016 | Pubmed ID: 26426441 [A YOUNG MAN WHOSE LDL-CHOLESTEROL IS GREATER THAN 1.9 G/L] La Revue Du Praticien. Oct, 2015 | Pubmed ID: 26749708 PCSK9 Inhibition: Does Lipoprotein Size Matter? Journal of the American Heart Association. Nov, 2015 | Pubmed ID: 26586733 Sotagliflozin As a Potential Treatment for Type 2 Diabetes Mellitus Expert Opinion on Investigational Drugs. 2015 | Pubmed ID: 26548423 MTOR Inhibitors and Diabetes Diabetes Research and Clinical Practice. Nov, 2015 | Pubmed ID: 26421362 Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody Circulation. Cardiovascular Genetics. Dec, 2015 | Pubmed ID: 26374825 Patient and Physician Perspectives on Mode of Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels Clinical Therapeutics. Sep, 2015 | Pubmed ID: 26278513 The Loss-of-function PCSK9 P.R46L Genetic Variant Does Not Alter Glucose Homeostasis Diabetologia. Sep, 2015 | Pubmed ID: 26049403 Clinical Use of Insulin Degludec Diabetes Research and Clinical Practice. Jul, 2015 | Pubmed ID: 25963320 Letter from Le May and Cariou Regarding Article, "Proprotein Convertase Subtilisin Kexin Type 9 Promotes Intestinal Overproduction of Triglyceride-rich Apolipoprotein B Lipoproteins Through Both Low-density Lipoprotein Receptor-dependent and -independent Mechanisms" Circulation. May, 2015 | Pubmed ID: 25940972 Role of PCSK9 Beyond Liver Involvement Current Opinion in Lipidology. Jun, 2015 | Pubmed ID: 25887680 Laparoscopic Gastric Banding in Obese Patients with Sleep Apnea: A 3-Year Controlled Study and Follow-up After 10 Years Obesity Surgery. Oct, 2015 | Pubmed ID: 25702144 Management of Thyroid Nodules Incidentally Discovered on MIBI Scanning for Primary Hyperparathyroidism Langenbeck's Archives of Surgery. Apr, 2015 | Pubmed ID: 25694271 Efficacy and Safety of Alirocumab in High Cardiovascular Risk Patients with Inadequately Controlled Hypercholesterolaemia on Maximally Tolerated Doses of Statins: the ODYSSEY COMBO II Randomized Controlled Trial European Heart Journal. May, 2015 | Pubmed ID: 25687353 PCSK9-deficiency Does Not Alter Blood Pressure and Sodium Balance in Mouse Models of Hypertension Atherosclerosis. Mar, 2015 | Pubmed ID: 25621930 Long-term Effects of Roux-en-Y Gastric Bypass on Postprandial Plasma Lipid and Bile Acids Kinetics in Female Non Diabetic Subjects: A Cross-sectional Pilot Study Clinical Nutrition (Edinburgh, Scotland). Oct, 2015 | Pubmed ID: 25306425 PCSK9 Inhibition with Evolocumab (AMG 145) in Heterozygous Familial Hypercholesterolaemia (RUTHERFORD-2): a Randomised, Double-blind, Placebo-controlled Trial Lancet (London, England). Jan, 2015 | Pubmed ID: 25282519 [Hormonal Evaluation of Adrenal Incidentalomas] Annales De Biologie Clinique. Nov-Dec, 2014 | Pubmed ID: 25486661 [Trans-intestinal Cholesterol Excretion (TICE): a New Route for Cholesterol Excretion] Medecine Sciences : M/S. Oct, 2014 | Pubmed ID: 25311025 Efficacy and Safety of Alirocumab, a Fully Human PCSK9 Monoclonal Antibody, in High Cardiovascular Risk Patients with Poorly Controlled Hypercholesterolemia on Maximally Tolerated Doses of Statins: Rationale and Design of the ODYSSEY COMBO I and II Trials BMC Cardiovascular Disorders. Sep, 2014 | Pubmed ID: 25240705 The Dual Peroxisome Proliferator-activated Receptor Alpha/delta Agonist GFT505 Exerts Anti-diabetic Effects in Db/db Mice Without Peroxisome Proliferator-activated Receptor Gamma-associated Adverse Cardiac Effects Diabetes & Vascular Disease Research. Nov, 2014 | Pubmed ID: 25212694 GFT505 for the Treatment of Nonalcoholic Steatohepatitis and Type 2 Diabetes Expert Opinion on Investigational Drugs. Oct, 2014 | Pubmed ID: 25164277 Preserved Adrenal Function in Fully PCSK9-deficient Subject International Journal of Cardiology. Sep, 2014 | Pubmed ID: 25062564 Congenital Lipodystrophies and Dyslipidemias Current Atherosclerosis Reports. Sep, 2014 | Pubmed ID: 25047893 [Management of Metabolic Disorders Induced by Everolimus in Patients with Differentiated Neuroendocrine Tumors: Expert Proposals] Bulletin Du Cancer. Feb, 2014 | Pubmed ID: 24557872 Mosaicism in HIF2A-related Polycythemia-paraganglioma Syndrome The Journal of Clinical Endocrinology and Metabolism. Feb, 2014 | Pubmed ID: 24276449 Endocrine Side Effects of Anti-cancer Drugs: Effects of Anti-cancer Targeted Therapies on Lipid and Glucose Metabolism European Journal of Endocrinology. Feb, 2014 | Pubmed ID: 24154684 Function of Seipin: New Insights from Bscl2/seipin Knockout Mouse Models Biochimie. Jan, 2014 | Pubmed ID: 23831461 Surgery for 'asymptomatic' Mild Primary Hyperparathyroidism Improves Some Clinical Symptoms Postoperatively European Journal of Endocrinology. Nov, 2013 | Pubmed ID: 23956299 A Standardized Vascular Disease Health Check in Europe: a Cost-effectiveness Analysis PloS One. 2013 | Pubmed ID: 23869204 Dual Peroxisome Proliferator-activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects Diabetes Care. Oct, 2013 | Pubmed ID: 23715754 Hepatoprotective Effects of the Dual Peroxisome Proliferator-activated Receptor Alpha/delta Agonist, GFT505, in Rodent Models of Nonalcoholic Fatty Liver Disease/nonalcoholic Steatohepatitis Hepatology (Baltimore, Md.). Dec, 2013 | Pubmed ID: 23703580 Transintestinal Cholesterol Excretion is an Active Metabolic Process Modulated by PCSK9 and Statin Involving ABCB1 Arteriosclerosis, Thrombosis, and Vascular Biology. Jul, 2013 | Pubmed ID: 23559630 Farnesoid X Receptor Inhibits the Transcriptional Activity of Carbohydrate Response Element Binding Protein in Human Hepatocytes Molecular and Cellular Biology. Jun, 2013 | Pubmed ID: 23530060 Plasma PCSK9 is a Late Biomarker of Severity in Patients with Severe Trauma Injury The Journal of Clinical Endocrinology and Metabolism. Apr, 2013 | Pubmed ID: 23450051 Plasma PCSK9 Concentrations During an Oral Fat Load and After Short Term High-fat, High-fat High-protein and High-fructose Diets Nutrition & Metabolism. Jan, 2013 | Pubmed ID: 23298392 New Avenues for the Pharmacological Management of Type 2 Diabetes: an Update Annales D'endocrinologie. Nov, 2012 | Pubmed ID: 23078974 Insulin Degludec Versus Insulin Glargine in Insulin-naive Patients with Type 2 Diabetes: a 1-year, Randomized, Treat-to-target Trial (BEGIN Once Long) Diabetes Care. Dec, 2012 | Pubmed ID: 23043166 Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Aug, 2012 | Pubmed ID: 22743249 Thiazolidinediones and PPARγ Agonists: Time for a Reassessment Trends in Endocrinology and Metabolism: TEM. May, 2012 | Pubmed ID: 22513163 DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Biochemical Pharmacology. Apr, 2012 | Pubmed ID: 22172989 [Management of Hypercholesterolemia: What Target for LDL Cholesterol?] La Revue Du Praticien. Oct, 2011 | Pubmed ID: 22135977 Lack of Association Between Plasma PCSK9 and LDL-apoB100 Catabolism in Patients with Uncontrolled Type 2 Diabetes Atherosclerosis. Nov, 2011 | Pubmed ID: 21889145 Effects of the New Dual PPAR α/δ Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients with Combined Dyslipidemia or Impaired Glucose Metabolism Diabetes Care. Sep, 2011 | Pubmed ID: 21816979 Fasting Plasma Chenodeoxycholic Acid and Cholic Acid Concentrations Are Inversely Correlated with Insulin Sensitivity in Adults Nutrition & Metabolism. Jul, 2011 | Pubmed ID: 21736725 Clinical Aspects of PCSK9 Atherosclerosis. Jun, 2011 | Pubmed ID: 21596380 Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity Diabetes. Jul, 2011 | Pubmed ID: 21593203 [Dyslipidemia] La Revue Du Praticien. Jan, 2011 | Pubmed ID: 21452556 The Farnesoid X Receptor Regulates Adipocyte Differentiation and Function by Promoting Peroxisome Proliferator-activated Receptor-gamma and Interfering with the Wnt/beta-catenin Pathways The Journal of Biological Chemistry. Nov, 2010 | Pubmed ID: 20851881 Association Between Plasma PCSK9 and Gamma-glutamyl Transferase Levels in Diabetic Patients Atherosclerosis. Aug, 2010 | Pubmed ID: 20452593 [Cholesterol Metabolism and Beta-cell Function] Medecine Sciences : M/S. Apr, 2010 | Pubmed ID: 20412743 PCSK9 is Expressed in Pancreatic Delta-cells and Does Not Alter Insulin Secretion Biochemical and Biophysical Research Communications. Dec, 2009 | Pubmed ID: 19878649 PCSK9 Dominant Negative Mutant Results in Increased LDL Catabolic Rate and Familial Hypobetalipoproteinemia Arteriosclerosis, Thrombosis, and Vascular Biology. Dec, 2009 | Pubmed ID: 19762784 High Protein Intake Reduces Intrahepatocellular Lipid Deposition in Humans The American Journal of Clinical Nutrition. Oct, 2009 | Pubmed ID: 19710199 A Corticotroph Pituitary Adenoma As the Initial Presentation of Familial Glucocorticoid Deficiency European Journal of Endocrinology. Jul, 2009 | Pubmed ID: 19423561 Proprotein Convertase Subtilisin Kexin Type 9 Null Mice Are Protected from Postprandial Triglyceridemia Arteriosclerosis, Thrombosis, and Vascular Biology. May, 2009 | Pubmed ID: 19265033 Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation Physiological Reviews. Jan, 2009 | Pubmed ID: 19126757 PCSK9 and LDL Cholesterol: Unravelling the Target to Design the Bullet Trends in Biochemical Sciences. Sep, 2008 | Pubmed ID: 18672372 Activation of the Farnesoid X Receptor Represses PCSK9 Expression in Human Hepatocytes FEBS Letters. Mar, 2008 | Pubmed ID: 18298956 Dual Mechanisms for the Fibrate-mediated Repression of Proprotein Convertase Subtilisin/kexin Type 9 The Journal of Biological Chemistry. Apr, 2008 | Pubmed ID: 18245819 FXR-deficiency Confers Increased Susceptibility to Torpor FEBS Letters. Nov, 2007 | Pubmed ID: 17950284 FXR: a Promising Target for the Metabolic Syndrome? Trends in Pharmacological Sciences. May, 2007 | Pubmed ID: 17412431 FXR: More Than a Bile Acid Receptor? Endocrinology. Sep, 2006 | Pubmed ID: 16912235 The Expanding Role of the Bile Acid Receptor FXR in the Small Intestine Journal of Hepatology. Jun, 2006 | Pubmed ID: 16618512 The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice The Journal of Biological Chemistry. Apr, 2006 | Pubmed ID: 16446356 Hepatic PCSK9 Expression is Regulated by Nutritional Status Via Insulin and Sterol Regulatory Element-binding Protein 1c The Journal of Biological Chemistry. Mar, 2006 | Pubmed ID: 16407292 Feasibility and Benefit of Fluorine 18-fluoro-2-deoxyglucose-guided Surgery in the Management of Radioiodine-negative Differentiated Thyroid Carcinoma Metastases Surgery. Dec, 2005 | Pubmed ID: 16360406 Transient Impairment of the Adaptive Response to Fasting in FXR-deficient Mice FEBS Letters. Aug, 2005 | Pubmed ID: 16023103 The Farnesoid X Receptor Modulates Hepatic Carbohydrate Metabolism During the Fasting-refeeding Transition The Journal of Biological Chemistry. Aug, 2005 | Pubmed ID: 15899888 Potential Regulatory Role of the Farnesoid X Receptor in the Metabolic Syndrome Biochimie. Jan, 2005 | Pubmed ID: 15733743 Farnesoid X Receptor: a New Player in Glucose Metabolism? Endocrinology. Mar, 2005 | Pubmed ID: 15713939 Peroxisome Proliferator-activated Receptor Alpha Induces NADPH Oxidase Activity in Macrophages, Leading to the Generation of LDL with PPAR-alpha Activation Properties Circulation Research. Dec, 2004 | Pubmed ID: 15539630 Increased Adipose Tissue Expression of Grb14 in Several Models of Insulin Resistance FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. Jun, 2004 | Pubmed ID: 15059968 Regulation and Functional Roles of Grb14 Frontiers in Bioscience : a Journal and Virtual Library. May, 2004 | Pubmed ID: 14977573 Cellular and Molecular Mechanisms of Adipose Tissue Plasticity in Muscle Insulin Receptor Knockout Mice Endocrinology. Apr, 2004 | Pubmed ID: 14684612 Inhibition of FGF Receptor Signalling in Xenopus Oocytes: Differential Effect of Grb7, Grb10 and Grb14 FEBS Letters. Jul, 2003 | Pubmed ID: 12885405 The Adapter Protein ZIP Binds Grb14 and Regulates Its Inhibitory Action on Insulin Signaling by Recruiting Protein Kinase Czeta Molecular and Cellular Biology. Oct, 2002 | Pubmed ID: 12242277 Inhibition of Insulin Receptor Catalytic Activity by the Molecular Adapter Grb14 The Journal of Biological Chemistry. Feb, 2002 | Pubmed ID: 11726652 Дуодено-подвздошное шунтирование с одним анастомозом и моделью рукавной гастрэктомии у мышей Samuel Frey1,2, Audrey Ayer1, Thibaud Sotin1, Victoria Lorant1, Bertrand Cariou1, Claire Blanchard*1,2, Cédric Le May*1 1CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes Université, 2Chirurgie Cancérologique, Digestive et Endocrinienne, Institut des Maladies de l'Appareil Digestif, Hôtel Dieu, CHU Nantes JoVE 64610 Medicine Методики Рукав гастрэктомия и Modified Ру-ан-Y желудочного шунтирования у мышей Audrey Ayer1, Frederic Borel1, Francois Moreau1, Xavier Prieur1, Michel Neunlist2, Bertrand Cariou3, Claire Blanchard*1,4, Cedric Le May*1 1l'Institut du Thorax, INSERM, CNRS, UNIV Nantes, 2CHU Nantes, Institut des Maladies de l'Appareil Digestif, INSERM U913, 3l'Institut du Thorax, INSERM, CNRS, UNIV Nantes, CHU Nantes, 4Service de Clinique Chirurgicale Digestive et Endocrinienne, CHU de Nantes Medicine
Дуодено-подвздошное шунтирование с одним анастомозом и моделью рукавной гастрэктомии у мышей Samuel Frey1,2, Audrey Ayer1, Thibaud Sotin1, Victoria Lorant1, Bertrand Cariou1, Claire Blanchard*1,2, Cédric Le May*1 1CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes Université, 2Chirurgie Cancérologique, Digestive et Endocrinienne, Institut des Maladies de l'Appareil Digestif, Hôtel Dieu, CHU Nantes JoVE 64610 Medicine
Методики Рукав гастрэктомия и Modified Ру-ан-Y желудочного шунтирования у мышей Audrey Ayer1, Frederic Borel1, Francois Moreau1, Xavier Prieur1, Michel Neunlist2, Bertrand Cariou3, Claire Blanchard*1,4, Cedric Le May*1 1l'Institut du Thorax, INSERM, CNRS, UNIV Nantes, 2CHU Nantes, Institut des Maladies de l'Appareil Digestif, INSERM U913, 3l'Institut du Thorax, INSERM, CNRS, UNIV Nantes, CHU Nantes, 4Service de Clinique Chirurgicale Digestive et Endocrinienne, CHU de Nantes Medicine
